XML 44 R2.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
Current assets    
Cash and cash equivalents $ 225,767 $ 181,381
Marketable securities 175,104 165,692
Accounts receivable, net 119,195 87,332
Inventories, net 24,418 26,628
Prepaid expenses and other current assets 12,564 11,611
Total current assets 557,048 472,644
Long term marketable securities 534,712 591,773
Property and equipment, net 18,011 17,068
Intangible assets, net 23,579 24,840
Lease assets 21,911 21,279
Deferred income taxes 34,067 32,063
Other assets 538 615
Total assets 1,189,866 1,160,282
Current liabilities    
Accounts payable 3,124 10,141
Accrued product returns and rebates 119,453 107,629
Accrued expenses and other current liabilities 33,003 37,130
Income taxes payable 9,097 2,443
Nonrecourse liability related to sale of future royalties, current portion 3,658 3,244
Total current liabilities 168,335 160,587
Convertible notes, net 349,232 345,170
Nonrecourse liability related to sale of future royalties, long term 18,369 19,248
Lease liabilities, long term 30,804 30,440
Other liabilities 9,743 9,409
Total liabilities 576,483 564,854
Stockholders’ equity    
Common stock, $0.001 par value; 130,000,000 shares authorized; 52,537,159 and 52,533,348 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively 53 53
Additional paid-in capital 392,430 388,410
Accumulated other comprehensive earnings (loss), net of tax (166) 7,417
Retained earnings 221,066 199,548
Total stockholders’ equity 613,383 595,428
Total liabilities and stockholders’ equity $ 1,189,866 $ 1,160,282